Patients with respiratory symptoms are at greater risk of COVID-19 transmission.
作者信息
Yang Rongrong, Gui Xien, Xiong Yong
机构信息
Department of Infectious Diseases, Zhongnan Hospital, Wuhan University, Wuhan, China.
Department of Infectious Diseases, Zhongnan Hospital, Wuhan University, Wuhan, China.
出版信息
Respir Med. 2020 Apr-May;165:105935. doi: 10.1016/j.rmed.2020.105935. Epub 2020 Mar 14.
Abstract
摘要
相似文献
1
Patients with respiratory symptoms are at greater risk of COVID-19 transmission.有呼吸道症状的患者感染新冠病毒的风险更高。
Respir Med. 2020 Apr-May;165:105935. doi: 10.1016/j.rmed.2020.105935. Epub 2020 Mar 14.
2
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19.粪便中严重 COVID-19 患者的感染性 SARS-CoV-2。
Emerg Infect Dis. 2020 Aug;26(8):1920-1922. doi: 10.3201/eid2608.200681. Epub 2020 May 18.
3
Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak.采用逆转录定量聚合酶链反应（RT-qPCR）检测与临床特征相结合的方法诊断新型冠状病毒肺炎（COVID-19），有助于对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫情进行管控。
J Med Virol. 2020 Jun;92(6):538-539. doi: 10.1002/jmv.25721. Epub 2020 Mar 11.
4
Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China.中国黄冈和泰安 194 例 COVID-19 患者的临床特征。
Infection. 2020 Oct;48(5):687-694. doi: 10.1007/s15010-020-01440-5. Epub 2020 May 10.
5
Risk factors for viral RNA shedding in COVID-19 patients.COVID-19 患者病毒 RNA 脱落的风险因素。
Eur Respir J. 2020 Jul 2;56(1). doi: 10.1183/13993003.01190-2020. Print 2020 Jul.
6
Presence and Duration of Symptoms in Febrile Infants With and Without SARS-CoV-2 Infection.发热婴儿中 SARS-CoV-2 感染与非感染的症状出现与持续时间。
Pediatr Infect Dis J. 2020 Nov;39(11):e372-e374. doi: 10.1097/INF.0000000000002858.
7
Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.临床特征：出院的 COVID-19 患者呼吸道样本中 SARS-CoV-2 RNA 阳性信号延长。
Virus Res. 2020 Sep;286:198047. doi: 10.1016/j.virusres.2020.198047. Epub 2020 Jun 6.
8
SARS-CoV-2: The viral shedding vs infectivity dilemma.严重急性呼吸综合征冠状病毒2：病毒脱落与传染性的困境。
Infect Dis Health. 2020 Aug;25(3):210-215. doi: 10.1016/j.idh.2020.05.002. Epub 2020 May 20.
9
Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.新型冠状病毒肺炎患者病毒 RNA 脱落停止的临床预测指标和时间。
J Clin Virol. 2020 Sep;130:104577. doi: 10.1016/j.jcv.2020.104577. Epub 2020 Aug 5.
10
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.SARS-CoV-2 RNA 存在于 COVID-19 患者的粪便中。
J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.
引用本文的文献
1
Risk factors for COVID-19 transmission in England: a multilevel modelling study using routine contact tracing data.英国新冠病毒传播的风险因素：一项使用常规接触者追踪数据的多层次建模研究
Epidemiol Infect. 2024 Oct 2;152:e112. doi: 10.1017/S0950268824001043.
2
Cough Audio Analysis for COVID-19 Diagnosis.用于新冠病毒疾病诊断的咳嗽音频分析
SN Comput Sci. 2023;4(2):125. doi: 10.1007/s42979-022-01522-1. Epub 2022 Dec 26.
3
Alternative SARS-CoV-2 detection protocol from self-collected saliva for mass diagnosis and epidemiological studies in low-incoming regions.来自低收入地区的大规模诊断和流行病学研究中，用于自我采集唾液的 SARS-CoV-2 替代检测方案。
J Virol Methods. 2022 Feb;300:114382. doi: 10.1016/j.jviromet.2021.114382. Epub 2021 Nov 27.
4
Tracking COVID-19 by Tracking Infectious Trajectories.通过追踪感染轨迹来追踪新冠病毒。
IEEE Access. 2020 Aug 7;8:145242-145255. doi: 10.1109/ACCESS.2020.3015002. eCollection 2020.
5
A longitudinal study on symptom duration and 60-day clinical course in non-hospitalised COVID-19 cases in Berlin, Germany, March to May, 2020.2020 年 3 月至 5 月，德国柏林对非住院 COVID-19 病例的症状持续时间和 60 天临床病程的纵向研究。
Euro Surveill. 2021 Oct;26(43). doi: 10.2807/1560-7917.ES.2021.26.43.2001757.
6
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia.SARS-CoV-2 刺突糖蛋白 S1 诱导 BV-2 小胶质细胞神经炎症。
Mol Neurobiol. 2022 Jan;59(1):445-458. doi: 10.1007/s12035-021-02593-6. Epub 2021 Oct 28.
7
Determining the communicable period of SARS-CoV-2: A rapid review of the literature, March to September 2020.确定 SARS-CoV-2 的传染期：2020 年 3 月至 9 月文献快速回顾。
Euro Surveill. 2021 Apr;26(14). doi: 10.2807/1560-7917.ES.2021.26.14.2001506.
8
Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review.新型冠状病毒肺炎实验室诊断的现状：一篇综述
Infect Drug Resist. 2020 Aug 3;13:2657-2665. doi: 10.2147/IDR.S264020. eCollection 2020.
9
Protecting healthcare workers during COVID-19 pandemic with nanotechnology: A protocol for a new device from Egypt.在 COVID-19 大流行期间使用纳米技术保护医护人员：来自埃及的新型设备方案。
J Infect Public Health. 2020 Sep;13(9):1243-1246. doi: 10.1016/j.jiph.2020.07.015. Epub 2020 Aug 3.
10
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.在感染过程中对 SARS-CoV-2 的检测、病毒载量和传染性。
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
本文引用的文献
1
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
2
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件